Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2023Sleep ScienceOpen Access

Daridorexant, a Recently Approved Dual Orexin Receptor Antagonists (DORA) in Treatment of Insomnia

View Full Paper
Ask AI
Bookmark
Share

Authors

DCDwaipayan Sarathi ChakrabortySCShouvik ChoudhurySLSandeep Lahiry

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Chakraborty et al. (2023) studied this question.

synapsesocial.com/papers/6a7e0461c108c8d3ff04645fhttps://doi.org/10.1055/s-0043-1770805
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Effect of the new dual orexin receptor antagonist daridorexant on nighttime respiratory function and sleep in patients with mild and moderate obstructive sleep apnea2020 · 45 citations
  2. 2The Quest for the Best Dual Orexin Receptor Antagonist (Daridorexant) for the Treatment of Insomnia Disorders2020 · 49 citations
  3. 3Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians2016 · 2,009 citations